Microbial Identification Market Bolstered by Demand in Agricultural Microbiology

The global microbial identification market size was valued at USD 4.19 billion in 2024 and is expected to reach USD 8.18 billion by 2030, expanding at a compound annual growth rate (CAGR) of 11.91% from 2025 to 2030. This significant growth is attributed to the rising prevalence of infectious diseases, rapid technological advancements, increased R&D efforts, and growing government investments in the biotechnology and life sciences sectors.

Moreover, heightened awareness regarding food safety and the need for effective environmental monitoring are key drivers anticipated to further fuel the market’s growth from 2025 onward. These factors are increasingly prompting industries and governments to adopt advanced microbial identification systems to ensure public health and safety.

Antimicrobial resistance (AMR)—the ability of microbes to resist the effects of medications—poses a serious global health threat. It leads to higher mortality rates, extended hospitalizations, and escalating healthcare costs. Accurate microbial identification plays a crucial role in combatting AMR by enabling precise, targeted treatment and minimizing the inappropriate use of broad-spectrum antibiotics.

With healthcare systems placing greater emphasis on antimicrobial stewardship, the demand for rapid and accurate microbial diagnostics is rising. Technologies like MALDI-TOF mass spectrometry, PCR-based systems, and next-generation sequencing (NGS) offer efficient detection of pathogens and resistant strains, allowing clinicians to make informed decisions and enhance patient outcomes. These tools are becoming essential components of modern infection control and treatment strategies.

According to the Global Research on Antimicrobial Resistance Project published in The Lancet in September 2024, the absence of effective interventions could result in over 39 million direct deaths from antibiotic-resistant bacterial infections within the next 25 years. Indirect deaths could reach an additional 169 million. By 2050, total deaths from AMR are projected to surge to 10.13 million annually, with an economic impact potentially reaching $1 trillion to $3.4 trillion in global GDP losses by 2030. These projections underscore the urgent need for reliable microbial identification methods.

International initiatives, such as the World Health Organization’s Global Action Plan on AMR, are encouraging governments to enhance surveillance systems and diagnostic infrastructures. In response, hospitals, research institutions, and laboratories are increasingly investing in advanced microbial identification technologies, reinforcing the market’s critical role in public health.

Order a free sample PDF of the Microbial Identification Market Intelligence Study, published by Grand View Research.

Key Market Trends & Insights

• North America led the global market with a 38.38% share in 2024.
• The U.S. microbial identification market is anticipated to witness strong growth throughout the forecast period.
• Consumables dominated the product & services segment with a 36.60% share in 2024.
• PCR technology accounted for the largest technology segment with a 36.69% share in 2024.
• The genotypic segment held the largest share at 42.19% in 2024 and is expected to record the highest CAGR from 2025 to 2030.

Market Size & Forecast

• 2024 Market Size: USD 4.19 Billion
• 2030 Market Size: USD 8.18 Billion
• CAGR (2025–2030): 11.91%
• North America: Largest regional market (2024)
• Asia Pacific: Fastest-growing region

Key Microbial Identification Company Insights

Leading market participants are employing strategies such as partnerships, mergers, and geographical expansions to enhance their footprint and drive product accessibility. These initiatives play a vital role in shaping industry dynamics and accelerating market growth.

Major Companies in the Microbial Identification Market:

• bioMérieux SA
• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc.
• Bruker Corporation
• Danaher Corporation
• Qiagen N.V.
• Charles River Laboratories
• Wickham Micro Limited
• VWR International LLC (Avantor Inc.)
• Shimadzu Corporation
• Merck KGaA
• Eurofins Scientific SE
• Biolog Inc

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The microbial identification market is poised for substantial growth through 2030, driven by the convergence of health priorities, technological progress, and global efforts to mitigate antimicrobial resistance. As awareness of microbial threats continues to grow, so too does the demand for accurate and timely identification tools. The integration of advanced technologies, coupled with supportive government and institutional initiatives, ensures that microbial identification will remain a cornerstone in the global strategy to protect public health, improve patient care, and curb the economic and medical impact of AMR.